Nektar Therapeutics NKTR
$73.02
-3.82%
at last close
Analyst Consensus
- Consensus Rating
- Buy (8 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $151.25
- Implied Upside
- +107.1%
- Price Target Range
- $80.00 – $192.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-22 | Canaccord GenuityEdward Nash |
Initiates coverage on | Buy | $153 |
| 2026-05-11 | WedbushMartin Fan |
Maintains | Neutral | $95 → $80 |
| 2026-05-08 | Piper SandlerYasmeen Rahimi |
Maintains | Overweight | $105 → $192 |
| 2026-04-21 | CitigroupSamantha Semenkow |
Maintains | Buy | $123 → $151 |
| 2026-04-21 | WedbushMartin Fan |
Maintains | Neutral | $70 → $95 |
| 2026-04-20 | HC Wainwright & Co.Arthur He |
Maintains | Buy | $165 → $185 |
| 2026-04-20 | BTIGJulian Harrison |
Maintains | Buy | $151 → $178 |
| 2026-03-24 | WedbushMartin Fan |
Initiates coverage on | Neutral | $70 |
| 2026-03-17 | TD CowenMarc Frahm |
Initiates coverage on | Buy | — |
| 2026-03-16 | CitigroupSamantha Semenkow |
Maintains | Buy | $102 → $123 |
| 2026-02-23 | B. Riley SecuritiesMayank Mamtani |
Reiterates | Buy | $105 → $150 |
| 2026-02-10 | HC Wainwright & Co.Arthur He |
Maintains | Buy | $135 → $165 |
| 2026-02-10 | BTIGJulian Harrison |
Maintains | Buy | $118 → $151 |
| 2026-01-29 | BTIGJulian Harrison |
Reiterates | Buy | $118 |
| 2025-12-16 | BTIGJulian Harrison |
Maintains | Buy | $100 → $118 |
| 2025-12-16 | HC Wainwright & Co.Arthur He |
Maintains | Buy | $120 → $135 |
| 2025-11-26 | CitigroupSamantha Semenkow |
Initiates coverage on | Buy | $102 |
| 2025-11-26 | JefferiesRoger Song |
Maintains | Buy | $99 → $121 |
| 2025-09-23 | B. Riley SecuritiesMayank Mamtani |
Maintains | Buy | $85 → $105 |
| 2025-09-19 | BTIGJulian Harrison |
Reiterates | Buy | $100 |
| 2025-07-08 | B. Riley SecuritiesMayank Mamtani |
Maintains | Buy | $60 → $85 |
| 2025-06-24 | HC Wainwright & Co.Arthur He |
Maintains | Buy | $7 → $120 |
| 2025-04-11 | JefferiesRoger Song |
Upgrades | Hold → Buy | $1 → $2 |
| 2025-03-14 | OppenheimerJay Olson |
Upgrades | Perform → Outperform | $6 |
| 2025-03-13 | HC Wainwright & Co.Arthur He |
Reiterates | Buy | $7 |
| 2025-02-25 | HC Wainwright & Co.Arthur He |
Reiterates | Buy | $7 |
| 2025-01-13 | HC Wainwright & Co.Arthur He |
Reiterates | Buy | $7 |
| 2025-01-08 | B. Riley SecuritiesMayank Mamtani |
Initiates coverage on | Buy | $4 |
| 2024-11-04 | Piper SandlerYasmeen Rahimi |
Initiates coverage on | Overweight | $7 |
| 2024-09-30 | BTIGRobert Hazlett |
Assumes | Buy | $4 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $73.02
- Market Cap
- $2.57 billion
- 52-Week Range
- $21.02 – $109.00
- Average Volume
- 734K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.